Droxidopa
Droxidopa is an orally active, blood-brain barrier permeable precursor to norepinephrine. It is utilized in research for neurogenic orthostatic hypotension (nOH) and as an alternative ADHD treatment model, with studies demonstrating its ability to elevate blood pressure and improve orthostatic tolerance in vivo.
Product Specifications
CAS Number
23651-95-8
Product Name Alternative
Inhibit, Inhibitor, orally active, neurogenic orthostatic hypotension, L-DOPS, AdrenergicReceptor, ADHD, Adrenergic Receptor, blood pressure, Beta Receptor, Droxidopa, DOPS, SM5688, SM-5688, SM 5688
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
97.27% (May vary between batches)
Solubility
H2O:1.25 mM; DMSO:2.14 mg/mL (10.04 mM)
Smiles
N[C@@H] ([C@H] (O) c1ccc (O) c (O) c1) C (O) =O
Molecular Formula
C9H11NO5
Molecular Weight
213.19
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1016162-01 0.02 mg (E-Coli)
Recombinant Salmonella newport Galactokinase (galK)
Sign In for Pricing
View Details MBS1016162-02 0.02 mg (Yeast)
Recombinant Salmonella newport Galactokinase (galK)
Sign In for Pricing
View Details MBS1016162-03 0.1 mg (E-Coli)
Recombinant Salmonella newport Galactokinase (galK)
Sign In for Pricing
View Details MBS1016162-04 0.1 mg (Yeast)
Recombinant Salmonella newport Galactokinase (galK)
Sign In for Pricing
View Details